|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0020823,
umls-concept:C0036525,
umls-concept:C0087111,
umls-concept:C0144576,
umls-concept:C0205195,
umls-concept:C0282460,
umls-concept:C0302592,
umls-concept:C0549379,
umls-concept:C0679729,
umls-concept:C1518578,
umls-concept:C1522484
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-6-7
|
|
pubmed:abstractText |
Ifosfamide, paclitaxel, and cisplatin have moderate single-agent activity in patients with metastatic or recurrent cancer of the uterine cervix. We administered a combination of these three agents to a large number of patients with metastatic or recurrent cervical cancer to evaluate its activity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
476-82
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12051877-Adult,
pubmed-meshheading:12051877-Aged,
pubmed-meshheading:12051877-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12051877-Cisplatin,
pubmed-meshheading:12051877-Disease Progression,
pubmed-meshheading:12051877-Drug Administration Schedule,
pubmed-meshheading:12051877-Female,
pubmed-meshheading:12051877-Humans,
pubmed-meshheading:12051877-Ifosfamide,
pubmed-meshheading:12051877-Infusions, Intravenous,
pubmed-meshheading:12051877-Middle Aged,
pubmed-meshheading:12051877-Neoplasm Metastasis,
pubmed-meshheading:12051877-Neoplasm Recurrence, Local,
pubmed-meshheading:12051877-Outpatients,
pubmed-meshheading:12051877-Paclitaxel,
pubmed-meshheading:12051877-Prospective Studies,
pubmed-meshheading:12051877-Survival Rate,
pubmed-meshheading:12051877-Uterine Cervical Neoplasms
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics and Radiotherapy, Alexandra Hospital, Athens, Greece. mdimop@med.uoa.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
